Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Citi
UBS
AstraZeneca
Federal Trade Commission
Fish and Richardson
Farmers Insurance
US Army
US Department of Justice

Generated: June 24, 2018

DrugPatentWatch Database Preview

DIDREX Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Didrex, and when can generic versions of Didrex launch?

Didrex is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in DIDREX is benzphetamine hydrochloride. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the benzphetamine hydrochloride profile page.
Summary for DIDREX
Drug patent expirations by year for DIDREX
Synonyms for DIDREX
(+)-benzphetamine
(+)-Benzphetamine hydrochloride
(+)-N-Benzyl-N,|A-dimethylphenethylamine Hydrochloride
(+)-N-benzyl-N,alpha-dimethylphenethylamine
(+)-N-Benzyl-N,alpha-dimethylphenethylamine hydrochloride
(+)-N,alpha-dimethyl-N-(phenylmethyl)-benzeneethanamine
(|AS)-N,|A-Dimethyl-N-(phenylmethyl)benzeneethanamine Hydrochloride
(2S)-N-benzyl-1-phenylpropan-2-amine hydrochloride (1:1)
(2S)-N-benzyl-1-phenylpropan-2-aminium chloride
(2S)-N-benzyl-N-methyl-1-phenylpropan-2-amine
(alphaS)-N,alpha-dimethylphenethylamine
(S)-(+)-benzphetamine
(S)-(+)-N-benzyl-N,alpha-dimethylphenethylamine
(S)-benzphetamine
(S)-Benzphetamine Hydrochloride
0M3S43XK27
156-08-1
43DWT87QT7
5411-22-3
AC1NSJU8
ANFSNXAXVLRZCG-RSAXXLAASA-N
benzaphetamine
Benzeneethanamine, N,alpha-dimethyl-N-(phenylmethyl)-, (+)-(9CI)
Benzfetamina
Benzfetamine
Benzfetamine (INN)
Benzfetamine [INN:BAN]
Benzfetaminum
Benzofetamina
benzphetamine
BENZPHETAMINE CHLORIDE
Benzphetamine HCl
BENZPHETAMINE HYDROCHLORIDE
BENZPHETAMINE HYDROCHLORIDE--DEA
Benzphetamine hydrochloride, United States Pharmacopeia (USP) Reference Standard
BENZPHETAMINEHYDROCHLORIDE--DEA
Benzphetaminum
benzyl(methyl)[(2S)-1-phenylpropan-2-yl]amine
Benzylamphetamine
CHEBI:3044
CHEBI:59169
CHEMBL3544906
CHEMBL3545985
D-N-Methyl-N-benzyl-beta-phenylisopropylamine
D0T5UL
DB00865
Didrex (TN)
DTXSID4022656
DTXSID6074837
MFCD00058090
N-Benzyl-N-methyl-1-phenyl-2-propanamine
N-benzyl-N-methyl-1-phenylpropan-2-amine
N-Benzyl-N,|A-dimethylphenethylamine hydrochloride
N-Benzyl-N,alpha-dimethylphenethylamine hydrochloride
N-methyl-1-phenyl-N-(phenylmethyl)propan-2-amine
N,alpha-Dimethyl-N-(phenylmethyl)benzeneethanamine
OR007446
OR009134
SCHEMBL260091
SCHEMBL49120
UNII-0M3S43XK27
UNII-43DWT87QT7
UNII-QZH832I91B component YXKTVDFXDRQTKV-HNNXBMFYSA-N
YXKTVDFXDRQTKV-HNNXBMFYSA-N
ZINC968305

US Patents and Regulatory Information for DIDREX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn DIDREX benzphetamine hydrochloride TABLET;ORAL 012427-003 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn DIDREX benzphetamine hydrochloride TABLET;ORAL 012427-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Boehringer Ingelheim
Express Scripts
Merck
Chubb
Citi
Johnson and Johnson
Accenture
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.